EL PASO, Texas (KFOX14/CBS4) — A doctoral student at the University of Texas at El Paso is digging deep with a new, less invasive way of undergoing a colonoscopy procedure. According to a statement ...
Scientists studied factors such as viral infections, gut microbiome, and exposome that could drive cancers, as well as how to ...
Hosted on MSN
What If Some Breast Cancers Aren't Really Cancer?
Ductal carcinoma in situ (DCIS) is a non-invasive breast condition found in nearly 20% of breast cancer diagnoses, but a growing number of doctors and medical experts are questioning whether the term ...
SAN FRANCISCO, May 22, 2025 /PRNewswire/ -- OncoSwab, a biotechnology company focused on early detection of cancer through non-invasive molecular testing, today announced it has entered into a ...
A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers from Vanderbilt University and the University of Michigan suggest this ...
When it comes to men's health, prostate cancer tends to fly under the radar. The disease can go undetected for years, especially in the early stages when symptoms may not be noticeable. Prostate ...
Landmark trials have driven a shift from radical mastectomies to less invasive, breast-conserving surgeries. Non-invasive breast carcinomas, when detected early, have highly favorable survival and ...
Cancer is typically treated with surgery, radiation and sometimes chemotherapy. But a new study suggests this standard protocol might not be necessary for a common form of early-stage breast cancer.
A drug used to relieve the debilitating symptoms of menopause may also be reducing the risk of invasive breast cancer, a new clinical trial by Northwestern University suggests. Almost 60,000 women a ...
TipRanks on MSN
Relmada’s BOOST phase 3 bladder cancer trial sets up a new catalyst for RLMD investors
Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...
Florian Willomitzer (left) and Madabhushi Balaji align their Synthetic Wavelength Imaging lab bench prototype to image non-melanoma skin cancer. The final prototype will be implemented in a portable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results